Intuitive Surgical (NSDQ:ISRG) said yesterday it submitted a premarket notification application to the FDA seeking clearance for its new flexible, robotic-assisted cahteter-based platform intended for use in the lungs.
The new platform is designed for navigation through very small lung airways to reach peripheral nodules for biopsies, the Sunnyvale, Calif.-based company said in a press release.
Intuitive Surgical did not release any other details of the tools.
In July, Intuitive Surgical saw shares rise in after-hours trading after the robotic surgical platform maker beat expectations on Wall Street with its second quarter results.
The post Intuitive Surgical seeks FDA approval for lung biopsy robotic platform tools appeared first on MassDevice.
from MassDevice https://ift.tt/2M6Ljr7
Cap comentari:
Publica un comentari a l'entrada